Skip to content

ERS LAB

Active
Private limited companyfounded 20242 yrs activeVoorspoedlaan 20, 1700 Dilbeek, BelgiumKBO/BCE: BE 1009.056.158
Summary

ERS LAB has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €9,857 and a net result of €9,857. Its solvency ranks better than 93% of 19922 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2024
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days acceptable
Liquidity ample (current ratio 25.68; short-term debt: 3.9% and cash: 0.1% of total assets), and 3.9% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
96.1%
Return on assets
96.1%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
35 d early
2024
31 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 2 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

ERS LAB was incorporated on 3 May 2024 as a Private limited company.1 The company has filed 2 sets of annual accounts, the latest for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
€9,857
Total assets
€10,256
Net result
€9,857
Working capital
€9,857

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Equity and liabilities €10,256
Equity €9,857
Debt €399
Debt finances 3.9% of the balance-sheet total.
Key figures and ratios
2024 value
Current ratio
25.68
Debt to equity
0.04
ROE
100.0%
ROA
96.1%
Debt ≤ 1 year
€399
Staff costs
€11,057

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
96% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 · 20 lines
Balance sheet Code2024
Assets
Total assets20/58€10,256
Current assets29/58€10,256
Amounts receivable within one year40/41€10,243
Trade receivables40€1,530
Other amounts receivable41€8,713
Cash at bank and in hand54/58€13
Equity and liabilities
Total equity and liabilities10/49€10,256
Equity10/15€9,857
Profit (loss) carried forward14€9,857
Amounts payable17/49€399
Amounts payable within one year42/48€399
Trade debts44€399
Suppliers440/4€399
Income statement Code2024
Remuneration, social security and pensions62€11,057
Gross operating margin9900€20,913
Operating profit (loss)9901€9,857
Profit (loss) for the period before taxes9903€9,857
Profit (loss) for the period9904€9,857
Profit (loss) for the period to be appropriated9905€9,857
Appropriation of the result
Profit (loss) to be appropriated9906€9,857
Line2024
Remuneration, social security and pensions62€11,057
Gross operating margin9900€20,913
Operating profit (loss)9901€9,857
Profit (loss) for the period before taxes9903€9,857
Profit (loss) for the period9904€9,857
Profit (loss) for the period to be appropriated9905€9,857
Line2024
Assets
Total assets20/58€10,256
Current assets29/58€10,256
Amounts receivable within one year40/41€10,243
Trade receivables40€1,530
Other amounts receivable41€8,713
Cash at bank and in hand54/58€13
Equity and liabilities
Total equity and liabilities10/49€10,256
Equity10/15€9,857
Profit (loss) carried forward14€9,857
Amounts payable17/49€399
Amounts payable within one year42/48€399
Trade debts44€399
Suppliers440/4€399
Line2024
Profit (loss) for the period9904€9,857
Operating cash flow (approximation)€9,857

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
26-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 31 days late
NBB filing
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
658 m²
Building footprint
164 m²
Volume, LiDAR
1,203 m³
2 parcels, Flanders · tallest building 11.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Itterbeeksebaan 111, 1700 Dilbeek
Human health activities
since 20242.359.101.960
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23352F0102/00D006 Flanders 373 m² 1 · 68 m² 10.6 m · 3 fl.
23352F0062/00N000 Flanders 284 m² 1 · 96 m² 11.3 m · 3 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 699 companies in sector 86910 we hold annual accounts for 522. 108 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded03-05-2024
Fiscal year end31-12
Activities, NACEBEL 2025
86910Medical imaging and medical laboratories
E-invoicing
Reachable via Peppol
Peppol ID 0208:1009056158
Also 9925:BE1009056158
Registered 11-12-2024

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.